433 related articles for article (PubMed ID: 15276195)
1. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.
Chou R; Peterson K; Helfand M
J Pain Symptom Manage; 2004 Aug; 28(2):140-75. PubMed ID: 15276195
[TBL] [Abstract][Full Text] [Related]
2. Muscle relaxants--the current position in the treatment of spasticity in orthopedics.
Zygmunt M; Sapa J
Ortop Traumatol Rehabil; 2015; 17(4):423-30. PubMed ID: 26468180
[TBL] [Abstract][Full Text] [Related]
3. Muscle relaxants for pain management in rheumatoid arthritis.
Richards BL; Whittle SL; Buchbinder R
Cochrane Database Syst Rev; 2012 Jan; 1():CD008922. PubMed ID: 22258993
[TBL] [Abstract][Full Text] [Related]
4. Comparative Risk of Opioid Overdose With Concomitant Use of Prescription Opioids and Skeletal Muscle Relaxants.
Khan NF; Bykov K; Barnett ML; Glynn RJ; Vine SM; Gagne JJ
Neurology; 2022 Sep; 99(13):e1432-e1442. PubMed ID: 35835561
[TBL] [Abstract][Full Text] [Related]
5. The Relative Efficacy of Seven Skeletal Muscle Relaxants. An Analysis of Data From Randomized Studies.
Abril L; Zamora C; Cordero M; Williams AR; Friedman BW
J Emerg Med; 2022 Apr; 62(4):455-461. PubMed ID: 35067395
[TBL] [Abstract][Full Text] [Related]
6. Treatments for spasticity and pain in multiple sclerosis: a systematic review.
Beard S; Hunn A; Wight J
Health Technol Assess; 2003; 7(40):iii, ix-x, 1-111. PubMed ID: 14636486
[TBL] [Abstract][Full Text] [Related]
7. Utilization Patterns of Skeletal Muscle Relaxants Among Commercially Insured Adults in the United States from 2006 to 2018.
Li Y; Delcher C; Reisfield GM; Wei YJ; Brown JD; Winterstein AG
Pain Med; 2021 Oct; 22(10):2153-2161. PubMed ID: 33690860
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle relaxants.
See S; Ginzburg R
Pharmacotherapy; 2008 Feb; 28(2):207-13. PubMed ID: 18225966
[TBL] [Abstract][Full Text] [Related]
9. A benefit-risk assessment of baclofen in severe spinal spasticity.
Dario A; Tomei G
Drug Saf; 2004; 27(11):799-818. PubMed ID: 15350152
[TBL] [Abstract][Full Text] [Related]
10. Choosing a skeletal muscle relaxant.
See S; Ginzburg R
Am Fam Physician; 2008 Aug; 78(3):365-70. PubMed ID: 18711953
[TBL] [Abstract][Full Text] [Related]
11. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
Olvey EL; Armstrong EP; Grizzle AJ
Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
[TBL] [Abstract][Full Text] [Related]
12. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone.
Toth PP; Urtis J
Clin Ther; 2004 Sep; 26(9):1355-67. PubMed ID: 15530999
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
Smolenski C; Muff S; Smolenski-Kautz S
Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for Spine-Related Pain in Older Adults.
Fu JL; Perloff MD
Drugs Aging; 2022 Jul; 39(7):523-550. PubMed ID: 35754070
[TBL] [Abstract][Full Text] [Related]
15. Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy.
Peck J; Urits I; Crane J; McNally A; Noor N; Patel M; Berger AA; Cornett EM; Kassem H; Kaye AD; Viswanath O
Psychopharmacol Bull; 2020 Oct; 50(4 Suppl 1):142-162. PubMed ID: 33633423
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review.
Taricco M; Pagliacci MC; Telaro E; Adone R
Eura Medicophys; 2006 Mar; 42(1):5-15. PubMed ID: 16565680
[TBL] [Abstract][Full Text] [Related]
17. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam.
Groves L; Shellenberger MK; Davis CS
Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943
[TBL] [Abstract][Full Text] [Related]
18. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.
Gracies JM; Nance P; Elovic E; McGuire J; Simpson DM
Muscle Nerve Suppl; 1997; 6():S92-120. PubMed ID: 9826984
[TBL] [Abstract][Full Text] [Related]
19. Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review.
Paisley S; Beard S; Hunn A; Wight J
Mult Scler; 2002 Aug; 8(4):319-29. PubMed ID: 12166503
[TBL] [Abstract][Full Text] [Related]
20. A Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone, Tizanidine, or Baclofen for Acute Low Back Pain.
Friedman BW; Irizarry E; Solorzano C; Zias E; Pearlman S; Wollowitz A; Jones MP; Shah PD; Gallagher EJ
Ann Emerg Med; 2019 Oct; 74(4):512-520. PubMed ID: 30955985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
